The present invention generally provides compositions methods and compositionrelating to the diagnosis and/or treatment of cancers having a cell surface de-N-acetylated sialic acid antigen, e.g., an at least partially de-N-acetylatedganglioside and/or a de-N-acetylated sialic acid-modified cell surface protein.